MedPath

Treatment of patients with severe periodontal disease by common periodontal cleaning or with surgery using an ultrasound device

Phase 4
Conditions
Chronic Periodontitis
C07.465.714.533.324
Registration Number
RBR-66vrz8
Lead Sponsor
niversidade Federal de Goiás
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Patients with diagnostic of chronic periodontitis, by presence of periodontal pockets with clinical attachment loss of 5 mm, with bleeding on probing, radiographic evidence of bilateral intrabony defect limited to two or three walls determined by periapical radiographs, and the absence of a medical condition that could affect the progression of periodontal disease.

Exclusion Criteria

Pregnant or lactating; smokers; Patients who required antibiotic premedication; patients who received antibiotic treatment in the previous 6 months; patients who received a course of periodontal treatment within the past 6 months; tooth with furcation involvements; tooth with endodontic treatment and non-vital tooth; tooth presenting mobility and/or traumatic occlusion.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected outcome 1: gain or loss of insertion verified through the relative level of clinical insertion, which was assessed from the base of the stent to the bottom of the periodontal pocket at the beginning of the study (21 days after the initial phase), 3 and 6 months after therapy by the same blind and calibrated examiner, using a standardized periodontal probe with 1-mm markings (PCPUNC 15, Hu-Friedy, Chicago, IL, USA) with a stent fabricated on acrylic guide (Bio-art, São Carlos, SP, Brazil) of probing to standardize the location and angulation of periodontal probes at the defects sites. ;Outcome found 1: In the study, gain of insertion was found at 3 and 6 months in the control and test groups (p <0.05), but there was no difference between groups at any time for this analysis parameter (p> 0.05).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath